Stay updated on Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate no ongoing participant enrollment. The page adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label, along with a revision note to v3.6.0 (replacing v3.5.5).
    Difference
    0.6%
    Check dated 2026-06-13T17:38:50.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer revision updated from v3.5.4 to v3.5.5, indicating a page rendering update that does not modify the clinical trial details or study data.
    Difference
    0.1%
    Check dated 2026-06-06T14:30:36.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    A new Revision label (v3.5.4) appears, replacing the previous v3.5.3. This reflects a minor product update to the page interface without altering study information.
    Difference
    0.1%
    Check dated 2026-05-16T09:32:47.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    ClinicalTrials.gov updated the page’s revision label from v3.5.2 to v3.5.3, indicating a site/version refresh rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-25T05:27:42.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:48:24.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-20T01:46:14.000Z thumbnail image

Stay in the know with updates to Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.